Esther O’Shea
About
Esther O’Shea is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Clinical Psychology.
According to data from OpenAlex, Esther O’Shea has authored 70 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cellular and Molecular Neuroscience, 44 papers in Toxicology and 30 papers in Clinical Psychology. Recurrent topics in Esther O’Shea's work include Forensic Toxicology and Drug Analysis (44 papers), Neurotransmitter Receptor Influence on Behavior (37 papers) and Psychedelics and Drug Studies (30 papers). Esther O’Shea is often cited by papers focused on Forensic Toxicology and Drug Analysis (44 papers), Neurotransmitter Receptor Influence on Behavior (37 papers) and Psychedelics and Drug Studies (30 papers). Esther O’Shea collaborates with scholars based in Spain, United Kingdom and Brazil. Esther O’Shea's co-authors include M. Isabel Colado, J.M. Elliott, María Isabel Colado, Annis O. Mechan, A. Richard Green, B. Moreno Esteban, R Granados, Verónica Sánchez, Jorge Camarero and María Dolores Gutiérrez‐López and has published in prestigious journals such as Scientific Reports, Brain Research and The FASEB Journal.
In The Last Decade
Esther O’Shea
70 papers receiving 4.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Esther O’Shea Spain | 34 | 2.5k | 2.4k | 1.7k | 1.4k | 427 | 70 | 4.0k | ||
| M. Isabel Colado Spain | 25 | 1.9k 0.7× | 1.8k 0.7× | 1.2k 0.7× | 1.0k 0.7× | 289 0.7× | 34 | 2.9k | ||
| María Isabel Colado Spain | 26 | 1.3k 0.5× | 966 0.4× | 666 0.4× | 570 0.4× | 379 0.9× | 64 | 2.2k | ||
| J.M. Elliott United Kingdom | 23 | 1.5k 0.6× | 1.1k 0.5× | 897 0.5× | 701 0.5× | 394 0.9× | 55 | 2.4k | ||
| Zuzana Justinová United States | 38 | 2.4k 1.0× | 345 0.1× | 191 0.1× | 2.0k 1.4× | 1.2k 2.7× | 65 | 3.7k | ||
| L S Melvin United States | 16 | 4.5k 1.8× | 844 0.3× | 342 0.2× | 6.4k 4.6× | 558 1.3× | 20 | 7.0k | ||
| Julián Romero Spain | 50 | 4.3k 1.7× | 421 0.2× | 133 0.1× | 6.3k 4.5× | 698 1.6× | 93 | 7.3k | ||
| Lisa A. Matsuda United States | 12 | 3.1k 1.2× | 488 0.2× | 153 0.1× | 4.8k 3.4× | 671 1.6× | 17 | 5.3k | ||
| Lesley Stevenson United Kingdom | 17 | 3.3k 1.3× | 730 0.3× | 192 0.1× | 5.9k 4.2× | 1.1k 2.5× | 30 | 6.7k | ||
| Donna Walther United States | 32 | 1.5k 0.6× | 338 0.1× | 215 0.1× | 403 0.3× | 1.3k 3.0× | 73 | 3.1k | ||
| Laura Orío Spain | 23 | 605 0.2× | 241 0.1× | 155 0.1× | 492 0.4× | 403 0.9× | 60 | 1.6k |
Countries citing papers authored by Esther O’Shea
Since
Specialization
Citations
This map shows the geographic impact of Esther O’Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther O’Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther O’Shea more than expected).
Fields of papers citing papers by Esther O’Shea
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Esther O’Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther O’Shea. The network helps show where Esther O’Shea may publish in the future.
Co-authorship network of co-authors of Esther O’Shea
This figure shows the co-authorship network connecting the top 25 collaborators of Esther O’Shea. A scholar is included among the top collaborators of Esther O’Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther O’Shea. Esther O’Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Malan‐Müller, Stefanie, Rebeca Vidal, Esther O’Shea, et al.. (2024). Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes. Translational Psychiatry. 14(1).
2.
Barreira, Bianca, Argentina Fernández, Javier Angulo, et al.. (2023). Oxidized soluble guanylyl cyclase causes erectile dysfunction in alcoholic mice. British Journal of Pharmacology. 180(18). 2361–2376.
3.
Vidal, Rebeca, et al.. (2022). Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice. British Journal of Pharmacology. 179(14). 3711–3726.
4.
Vidal, Rebeca, et al.. (2021). Addiction and the kynurenine pathway: A new dancing couple?. Pharmacology & Therapeutics. 223. 107807–107807.
5.
Ballestín, Raúl, Rebeca Vidal, Carmen Ferrer‐Pérez, et al.. (2021). Decreased kynurenine pathway potentiate resilience to social defeat effect on cocaine reward. Neuropharmacology. 197. 108753–108753.
6.
Vidal, Rebeca, Nuria García‐Marchena, Esther O’Shea, et al.. (2020). Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 102. 109958–109958.
7.
Fernández-Valle, María Encarnación, Ana Rubio‐Araiz, Rebeca Vidal, et al.. (2017). 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus. Neuropharmacology. 118. 157–166.
8.
Urrutia, Andrés A., Ana Rubio‐Araiz, María Dolores Gutiérrez‐López, et al.. (2012). A study on the effect of JNK inhibitor, SP600125, on the disruption of blood–brain barrier induced by methamphetamine. Neurobiology of Disease. 50. 49–58.
9.
Ares‐Santos, Sara, Noelia Granado, Idaira Oliva, et al.. (2011). Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine. Neurobiology of Disease. 45(2). 810–820.
10.
Izco, María, Ivanny Marchant, Isabel Escobedo, et al.. (2007). Mice with Decreased Cerebral Dopamine Function following a Neurotoxic Dose of MDMA (3,4-Methylenedioxymethamphetamine, “Ecstasy”) Exhibit Increased Ethanol Consumption and Preference. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1003–1012.
11.
Izco, María, Laura Orío, Esther O’Shea, & M. Isabel Colado. (2006). Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain. Psychopharmacology. 189(4). 459–470.
12.
O’Shea, Esther, Laura Orío, Isabel Escobedo, et al.. (2006). MDMA‐induced neurotoxicity: long‐term effects on 5‐HT biosynthesis and the influence of ambient temperature. British Journal of Pharmacology. 148(6). 778–785.
13.
O’Shea, Esther, et al.. (2005). The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA (‘ecstasy’) when housed at high ambient temperature. Psychopharmacology. 179(4). 884–890.
14.
Orío, Laura, Esther O’Shea, Verónica Sánchez, et al.. (2004). 3,4‐Methylenedioxymethamphetamine increases interleukin‐1β levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5‐HT depletion. Journal of Neurochemistry. 89(6). 1445–1453.
15.
Sánchez, Verónica, et al.. (2004). Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones. Journal of Psychopharmacology. 18(3). 412–416.
16.
Sánchez, Verónica, Miriam Zeini, Jorge Camarero, et al.. (2003). The nNOS inhibitor, AR‐R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum. Journal of Neurochemistry. 85(2). 515–524.
17.
Mechan, Annis O., et al.. (2003). The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pharmacological Reviews. 55(3). 463–508.
18.
Cole, Jon C., Harry Sumnall, Esther O’Shea, & C.A. Marsden. (2003). Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology. 166(4). 383–390.
19.
O’Shea, Esther, Verónica Sánchez, Jorge Camarero, A. Richard Green, & María Isabel Colado. (2002). On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitor. Psychopharmacology. 165(3). 317–319.
20.
Colado, María Isabel, Esther O’Shea, R Granados, Tracey K. Murray, & A R Green. (1997). In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine. British Journal of Pharmacology. 121(5). 889–900.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by M. Isabel Colado Breakdown of academic impact, for papers by María Isabel Colado Breakdown of academic impact, for papers by J.M. Elliott Breakdown of academic impact, for papers by Zuzana Justinová Breakdown of academic impact, for papers by L S Melvin Breakdown of academic impact, for papers by Julián Romero Breakdown of academic impact, for papers by Lisa A. Matsuda Breakdown of academic impact, for papers by Lesley Stevenson Breakdown of academic impact, for papers by Donna Walther Breakdown of academic impact, for papers by Laura Orío